5 Can’t-Miss Health-Care Events This Week: Dynavax Technologies Corporation (DVAX) and More

Highly embattled nutritional-products supplier Herbalife Ltd. (NYSE:HLF) is also slated to report its fourth-quarter results on Tuesday. Wall Street’s expectations are for 19% sales growth to $1.05 billion and for EPS to expand to $1.03 from $0.86 in the previous year. Normally these results wouldn’t take center stage, but with activist investors Bill Ackman, who has a gigantic short position, and Carl Icahn, who has disclosed a very sizable long position, involved, the implications of this report are enormous. Herbalife’s business has always concerned me from a customer loyalty aspect, and I’m avoiding the stock at the moment, but that won’t keep me from thoroughly examining its fourth-quarter results and 2013 forecast.

Last, but certainly not least, health-benefits provider Express Scripts Holding Company (NASDAQ:ESRX) has said “no” to taking the day off on Monday and is expected to report its fourth-quarter results on that date. These results will include Express Scripts’ figures since the resolution of its spat with Walgreen Company (NYSE:WAG) in September. Another key point worth watching is how the company is advancing with regard to synergies associated with its gigantic Medco Health Solutions purchase. A few months ago, the companies looked ahead of schedule with their integration but then appeared to take a step back in the third quarter, when low utilization rates and in-member attrition sacked revenue growth. This synergy will be the key to driving growth going forward and is a point worth keying in on.

The article 5 Can’t-Miss Health-Care Events This Week originally appeared on Fool.com and is written by Sean Williams.

Fool contributor Sean Williams has no material interest in any companies mentioned in this article. You can follow him on CAPS under the screen name TMFUltraLong, track every pick he makes under the screen name TrackUltraLong, and check him out on Twitter, where he goes by the handle @TMFUltraLong.The Motley Fool recommends Exelixis and Express Scripts; owns shares of Exelixis, Express Scripts, and Medtronic; and has options on Herbalife.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.